TARGETED TEMPERATURE MANAGEMENT — NON-INVASIVE

BD Arctic Sun 5000

A BD targeted temperature management (TTM) system — it cools, warms or maintains the patient's core temperature non-invasively, through ArcticGel™ hydrogel pads applied to ~40% of the body surface. Closed-loop with micro-adjustments every 2 minutes for ±0.2 °C accuracy in therapeutic hypothermia after cardiac arrest, TBI, stroke and refractory-fever management in the ICU.

Model: BD Arctic Sun 5000

BD Arctic Sun 5000 — targeted temperature management
32–38,5°Cpatient target temperature range
~2 minclosed-loop micro-adjustments
~40%body surface covered
4–42°Ccirculated water temperature

THE TECHNOLOGY

Surface cooling with hydrogel pads + closed-loop control

The Arctic Sun 5000 controls the patient's core temperature by circulating temperature-regulated water through adhesive ArcticGel™ hydrogel pads applied to the chest and thighs. Unlike intravascular systems with a femoral catheter, the non-invasive approach reduces the risk of infection and DVT, with no additional cannulation.

The closed-loop algorithm continuously receives the temperature from the central probe (bladder, esophagus, YSI-400) and makes micro-adjustments every ~2 minutes — ~30 adjustments/hour — to keep the patient exactly within the target range. The high accuracy (±0.2–0.3 °C in studies) makes Arctic Sun the reference device in randomised trials of therapeutic hypothermia after cardiac arrest.

  • Adhesive ArcticGel™ pads — efficient thermal transfer through hydrogel
  • Closed-loop control with a central probe (YSI-400 series)
  • Micro-adjustments every ~2 minutes — ±0.2 °C accuracy in the clinical literature
  • Negative-pressure water circuit — low leak risk
  • Pad sizes: large, medium, small universal, neonatal
  • Touchscreen with patient trend + treatment-history storage

VIDEO

Arctic Sun 5000 — clinical overview

AVAILABLE THERAPIES

Four thermal-management modes

The Arctic Sun 5000 covers the full spectrum of ICU thermal management — from therapeutic hypothermia after cardiac arrest to controlled intra- and post-operative normothermia.

HYPOTHERMIA

Therapeutic cooling after cardiac arrest

Active cooling to 32–36 °C in the first hours post-ROSC for neuroprotection. Indicated per ERC/AHA guidelines — it significantly improves neurologically intact survival. Rapid cooling (~1.5 °C/h with optimally applied pads).

  • Target 32–36 °C (mild hypothermia)
  • Rapid active cooling (~1.5 °C/h)
  • Indicated post-ROSC for neuroprotection
  • Recommended by ERC 2021, AHA Guidelines

REWARMING

Controlled rewarming

After the hypothermia phase, slow and controlled rewarming (~0.25 °C/h or a custom setting). It prevents the complications of overly rapid rewarming: hypotension, hypoglycemia, dangerous vasodilation.

  • Configurable rewarming rate (~0.1–0.5 °C/h)
  • Prevents rewarming hypotension
  • Automatic transition to normothermia
  • Essential for the full TTM protocol

FEVER

Refractory fever management

ICU patients with fever refractory to antipyretics (post-stroke, TBI, sepsis) — Arctic Sun actively keeps the temperature below 37.5 °C, preventing the neurological deterioration associated with hyperthermia.

  • Target below 37.5 °C (controlled normothermia)
  • Effective when antipyretics no longer work
  • Indicated post-stroke, TBI, sepsis, status epilepticus
  • Reduces hyperthermic neurological deterioration

NORMOTHERMIA

Targeted normothermia — intra/post-operative

Maintaining the temperature at 36.5 °C during long procedures (cardiac, neuro) and in the first 24h post-operatively. It reduces the complications associated with accidental hypothermia: infections, bleeding, cardiac ischemia.

  • Target 36.5 °C — anti-shivering
  • Used in cardiac, neuro and transplant surgery
  • Reduces post-operative infection rates
  • Compatible with long procedures

TECHNICAL SPECIFICATIONS

BD Arctic Sun 5000 operating parameters

Target temperature range32,0 – 38,5 °C
Circulated water temperature~4 – 42 °C
Heating power~750 W (~2.500 BTU/h)
Water flow through pads~5 L/min
Reservoir capacity~3.5 L (distilled or sterile water)
Closed-loop controlMicro-adjustments every ~2 min (~30/h)
Temperature probeYSI-400 — bladder, esophageal (optional secondary probe)
Pad coverage~30–40% of body surface (4 standard pads)
Pad sizesLarge · Medium · Small universal · Neonatal
InterfaceColour touchscreen with patient trend
Treatment memoryStores ~10 case histories
SafetyNegative-pressure water circuit (low leak risk)
Console dimensions~89 × 36–47 × 47 cm (H×L×A)
Weight~43 kg empty / ~47 kg with water
ComplianceCE Mark (Class IIb) · FDA 510(k) cleared (2010)

CLINICAL INDICATIONS

Where the Arctic Sun 5000 makes the difference

  • Post-ROSC cardiac arrest

    Therapeutic hypothermia at 32–36 °C for comatose post-resuscitation patients. ERC / AHA guideline standard.

  • Traumatic brain injury (TBI)

    Thermal control for neuroprotection and central-fever (ICP) management.

  • AVC ischemic / hemoragic

    Controlled normothermia below 37.5 °C — reduces hyperthermic neurological deterioration.

  • ICU / Neuro-ICU

    Management of fever refractory to antipyretics, status epilepticus, encephalitis.

  • Cardiac / neuro surgery

    Intra- and post-operative normothermia to reduce thermal complications.

  • Sepsis / septic state

    Thermal control to reduce metabolic consumption and cardiovascular demand.

WHY THE BD Arctic Sun 5000

The gold standard for non-invasive TTM

Arctic Sun is the device used in most randomised trials of therapeutic hypothermia after cardiac arrest over the past 20 years. The non-invasive approach eliminates the infection / DVT risk associated with intravascular catheters, and the hydrogel pads provide significantly more efficient thermal transfer than classic warm-water blankets. The closed-loop algorithm with micro-adjustments every 2 minutes provides consistent accuracy, essential for modern TTM protocols.

  • Non-invasive — no catheter, minimal infection / DVT risk
  • ArcticGel™ pads — thermal transfer superior to blankets
  • Closed-loop with micro-adjustments every 2 min — ±0.2 °C accuracy
  • The reference device in international TTM studies
  • CE marked · FDA 510(k) cleared

Interested in the BD Arctic Sun 5000?

Hellimed provides technical consulting, clinical demonstrations, TTM-protocol training and ArcticGel™ pads — for ICU, neuro-ICU, post-cardiac therapy and the operating room.

Request a quote for the Arctic Sun 5000